Posts | Comments | Contact



Vivus, Inc. (NASD:VVUS) Seasonal Chart

Vivus, Inc. (NASD:VVUS) Seasonality

VVUS Relative to the S&P 500
VVUS Relative to the S&P 500

VVUS Relative to the Sector
VVUS Relative to the Sector

Monthly Seasonal Vivus, Inc. (NASD:VVUS)

Seasonal Chart Analysis

Analysis of the Vivus, Inc. (NASD:VVUS) seasonal charts above shows that a Buy Date of December 7 and a Sell Date of March 10 has resulted in a geometric average return of 9.89% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 29.32% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

VIVUS Incis a biopharmaceutical company engaged in the
development and commercialization of therapeutic products for large underserved
markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile
dysfunction.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...